Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus M Rinschen

Showing results (111-120 of 116) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 116 results.
The Journal of Clinical Investigation|April 4, 2023
Accumulation of α-synuclein mediates podocyte injury in Fabry nephropathyFabian Braun, Ahmed Abed, Dominik Sellung, et al.
The EMBO Journal|October 28, 2025
Proteolytic profiling of human plasma reveals an immunoactive complement C3 fragmentFatih Demir, Elina Kovalenko, Moritz Lassé, et al.
Nature Communications|August 14, 2023
An integrated organoid omics map extends modeling potential of kidney diseaseMoritz Lassé, Jamal El Saghir, Celine C Berthier, et al.
Nature Reviews. Nephrology|July 28, 2025
Microbiota and kidney disease: the road aheadPatricia P Bloom, Wendy S Garrett, Kristina L Penniston, et al.
Nature Communications|December 20, 2024
Author Correction: Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathwaysNaziia Kurmasheva, Aida Said, Boaz Wong, et al.
Nature Communications|May 15, 2024
Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathwaysNaziia Kurmasheva, Aida Said, Boaz Wong, et al.
Pageof 12

Showing results (111-120 of 116) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 116 results.
The Journal of Clinical Investigation|April 4, 2023
Accumulation of α-synuclein mediates podocyte injury in Fabry nephropathyFabian Braun, Ahmed Abed, Dominik Sellung, et al.
The EMBO Journal|October 28, 2025
Proteolytic profiling of human plasma reveals an immunoactive complement C3 fragmentFatih Demir, Elina Kovalenko, Moritz Lassé, et al.
Nature Communications|August 14, 2023
An integrated organoid omics map extends modeling potential of kidney diseaseMoritz Lassé, Jamal El Saghir, Celine C Berthier, et al.
Nature Reviews. Nephrology|July 28, 2025
Microbiota and kidney disease: the road aheadPatricia P Bloom, Wendy S Garrett, Kristina L Penniston, et al.
Nature Communications|December 20, 2024
Author Correction: Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathwaysNaziia Kurmasheva, Aida Said, Boaz Wong, et al.
Nature Communications|May 15, 2024
Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathwaysNaziia Kurmasheva, Aida Said, Boaz Wong, et al.
Pageof 12